The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

St. Jude Medical Inc

NYSE: STJ
Last

(U.S.) $50.30

Today's change0.00 0.00%
Updated February 8 4:01 PM EST. Delayed by at least 15 minutes.
 

St. Jude Medical Inc

NYSE: STJ
Last

(U.S.) $50.30

Today's change0.00 0.00%
Updated February 8 4:01 PM EST. Delayed by at least 15 minutes.

St. Jude Medical Inc closed at (U.S.)$50.30.

Over the last five days, shares have lost 5.63% and sit 2.03% above their 52-week low. This security has underperformed the S&P 500 by 14.20% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $50.30
  • High--
  • Low--
  • Bid / Ask(U.S.) $48.89 / (U.S.) $50.18
  • YTD % change-18.57%
  • Volume0
  • Average volume (10-day)2,770,098
  • Average volume (1-month)2,478,715
  • Average volume (3-month)2,055,919
  • 52-week range(U.S.) $49.30 to (U.S.) $80.84
  • Beta1.34
  • Trailing P/E16.36×
  • P/E 1 year forward12.63×
  • Forward PEG1.20×
  • Indicated annual dividend(U.S.) $1.16
  • Dividend yield2.31%
  • Trailing EPS(U.S.) $3.07
Updated February 8 4:01 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+15.63%

Based on its net profit margin of 15.63%, St. Jude Medical Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJan 02, 201601/02/2016Oct 03, 201510/03/2015Jul 04, 201507/04/2015Apr 04, 201504/04/2015
Revenue1,4471,3391,4101,345
Total other revenue--------
Total revenue1,4471,3391,4101,345
Gross profit946914986950
Total cost of revenue501425424395
Total operating expense1,3501,0451,0961,020
Selling / general / administrative588413447430
Research & development177161171167
Depreciation / amortization45232424
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total3923304
Operating income97294314325
Interest income (expense), net non-operating---22-20-21
Gain (loss) on sale of assets--------
Other--------
Income before tax65261294308
Income after tax113215282256
Income tax, total-48461252
Net income113215290262
Total adjustments to net income--------
Net income before extra. items113215290262
Minority interest0086
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items113215290262
Inc. avail. to common incl. extra. items113215290262
Diluted net income113215290262
Dilution adjustment--0----
Diluted weighted average shares287286286287
Diluted EPS excluding extraordinary itemsvalue per share0.390.751.020.91
Dividends per sharevalue per share0.290.290.290.29
Diluted normalized EPSvalue per share0.840.751.020.91